share_log

TD Cowen Maintains Buy on Elevance Health, Lowers Price Target to $589

TD Cowen Maintains Buy on Elevance Health, Lowers Price Target to $589

TD Cowen维持对Elevance Health的买入评级,将目标价下调至589美元
Benzinga ·  07/19 12:42

TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and lowers the price target from $624 to $589.

TD Cowen分析师Ryan Langston维持对Elevance Health(纽交所:ELV)的买入评级,并将价格目标下调至589美元,原价为624美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发